Glenmark Pharmaceuticals USA
Pharmaceutical manufacturing
Based in NJ
🤖
AI Overview
With $4.2M in lobbying spend across 27 quarterly filings, Glenmark Pharmaceuticals USA is a significant lobbying presence. Their lobbying covers 2 issue areas. Active from 2018 to 2024.
$4.2M
Total Spend
7
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $842K |
| 2019 | $1.0M |
| 2020 | $897K |
| 2021 | $897K |
| 2022 | $601K |
| 2023 | $0 |
| 2024 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
- •Prescription drug costs
- •Medicaid Generics Penalty, Medicaid Rebates
- •Medicaid Generics Penalty
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.